Submitted by Anonymous (not verified) on 16 September 2026 - 15:03
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 5, Status: Authorised